β-Lactams as inhibitors of human Fatty Acid Amide Hydrolase: synthesis and pharmacological testing
(2013) 18th European Symposium on Organic Chemistry — Location: (France) Marseille (7.July.2013)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- A series of lipophilic ester derivatives (2a-g) of (S)-1-(pent-4’-enoyl)-4-(hydroxymethyl)-azetidin-2-one has been synthesized in three steps from (S)-4-(benzyloxycarbonyl)-azetidin-2-one and evaluated as novel, reversible, -lactamic inhibitors of endocannabinoid-degrading enzymes (hFAAH and hMAGL). The compounds showed IC50 values in the micromolar range and selectivity for hFAAH versus hMAGL. The unexpected thousandfold decrease of activity of 2a comparatively to the known regioisomeric structure 1a (i.e. lipophilic chains placed on N1 and C3 positions of the -lactam core) could be explained on the basis of docking studies into a revisited model of hFAAH active site, considering one or two water molecules in interaction with the catalytic triad.
- Affiliations
Citations
Caruano, J., Feledziak, M., Muccioli, G., Marchand-Brynaert, J., & Robiette, R. (2013). β-Lactams as inhibitors of human Fatty Acid Amide Hydrolase: synthesis and pharmacological testing. 18th European Symposium on Organic Chemistry, (France) Marseille. https://hdl.handle.net/2078.5/200788